PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - O'Connor, Patrick J.
TI  - Combined Intensive BP and Glycemic Control Has No Benefit in Reducing CV Risk in Patients with T2DM
DP  - 2011 Dec 01
TA  - MD Conference Express
PG  - 15--15
VI  - 11
IP  - 11
4099  - http://mdc.sagepub.com/content/11/11/15.1.short
4100  - http://mdc.sagepub.com/content/11/11/15.1.full
AB  - The Action to Control Cardiovascular Risk in Diabetes [ACCORD] study was a randomized, multicenter clinical trial [NCT00000620] that was conducted in 77 clinical sites in the United States and Canada. None of the ACCORD prespecified microvascular outcomes was significantly reduced in participants who were intensively treated for both glycemia and BP compared with those who were treated with either regimen alone, signifying the lack of an additional beneficial effect from combined intensive treatment.